We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
-24.42%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$4.95B
AUM Growth
-$3.47B
Cap. Flow
+$352M
Cap. Flow %
7.11%
Top 10 Hldgs %
77.21%
Holding
70
New
7
Increased
1
Reduced
6
Closed
12

Top Buys

Rank Stock Value
1
IONQ icon
IonQ
IONQ
+$487M
2
NET icon
Cloudflare
NET
+$166M
3
BZFD icon
BuzzFeed
BZFD
+$135M
4
UTRS
Minerva Surgical, Inc. Common Stock
UTRS
+$71.1M
5
NN icon
NextNav
NN
+$70.1M

Top Sells

Rank Stock Value
1
BILL icon
BILL Holdings
BILL
+$140M
2
HOOD icon
Robinhood
HOOD
+$103M
3
TRIL
Trillium Therapeutics Inc.
TRIL
+$101M
4
VECT
VectivBio Holding AG Ordinary Shares
VECT
+$51.8M
5
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$49.8M

Sector Composition

Rank Sector Weight
1 Healthcare 41.06%
2 Financials 26.07%
3 Technology 16.75%
4 Consumer Staples 7.84%
5 Industrials 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFMD
26
DELISTED
Affimed
AFMD
$24.4M 0.49%
442,649
– –
EAR
27
DELISTED
Eargo, Inc. Common Stock
EAR
$23.1M 0.47%
226,034
– –
LITS
28
Lite Strategy Inc
LITS
$31.6M
$22.8M 0.46%
426,654
– –
ALLK
29
DELISTED
Allakos
ALLK
$21.2M 0.43%
2,164,704
– –
MILE
30
DELISTED
Metromile, Inc. Common Stock
MILE
$20.6M 0.42%
9,384,285
– –
AVEO
31
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$18.5M 0.37%
3,952,958
– –
BDTX icon
32
Black Diamond Therapeutics
BDTX
$110M
$18.4M 0.37%
3,449,845
– –
IVA
33
Inventiva
IVA
$1.1B
$17.7M 0.36%
1,298,700
– –
CTIC
34
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$17.7M 0.36%
7,140,450
– –
PHAS
35
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$17.3M 0.35%
6,643,704
– –
INZY
36
DELISTED
Inozyme Pharma
INZY
$16.7M 0.34%
2,444,379
– –
BILL icon
37
BILL Holdings
BILL
$4.68B
$16.5M 0.33%
66,070
-494,704
-88% -$140M
GERN icon
38
Geron
GERN
$1.01B
$16.4M 0.33%
13,461,538
– –
CSBR icon
39
Champions Oncology
CSBR
$72.1M
$14.3M 0.29%
1,713,720
– –
STSA
40
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$14.1M 0.29%
3,142,958
– –
CBIO
41
Crescent Biopharma
CBIO
$610M
$13.1M 0.26%
90,890
– –
GNCA
42
DELISTED
Genocea Biosciences, Inc.
GNCA
$12M 0.24%
10,376,936
– –
ANNX icon
43
Annexon
ANNX
$918M
$10.4M 0.21%
901,537
-1,457,069
-62% -$23.5M
SYBX
44
DELISTED
Synlogic
SYBX
$10.2M 0.21%
281,961
– –
MRKR icon
45
Marker Therapeutics
MRKR
$18.7M
$10.2M 0.21%
1,071,429
– –
XERS icon
46
Xeris Biopharma Holdings
XERS
$1.27B
$9.52M 0.19%
+3,250,000
New +$7.02M
LXRX icon
47
Lexicon Pharmaceuticals
LXRX
$1.05B
$9.39M 0.19%
2,382,286
– –
OBSV
48
DELISTED
ObsEva SA Ordinary Shares
OBSV
$9.13M 0.18%
4,586,563
– –
ELVN icon
49
Enliven Therapeutics
ELVN
$4.31B
$8.07M 0.16%
896,593
-107,700
-11% -$1.41M
MIMO
50
DELISTED
Airspan Networks Holdings Inc
MIMO
$5.81M 0.12%
+1,534,140
New +$9.08M
1
2
3

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
GD
Grandfield & Dodd New York $1.77B AUM 23.43% 1-Year Est. Return
DF
DNCA Finance Paris, France $1.75B AUM 38.18% 1-Year Est. Return
HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return

NEA Management Company's Q4 2021 Portfolio in Review

As of Q4 2021, NEA Management Company held 70 positions worth $4.95B, down 41% from $8.42B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

NEA Management Company deployed $352M of net new capital in Q4 2021, opening 7 new positions and adding to 1 existing holding. Its largest new stake was IonQ: 29,229,659 shares worth $488M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 48% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was BILL Holdings, an estimated $140M trimmed.

  • NEA Management Company's largest Q4 2021 buy was IonQ: 29,229,659 shares worth $488M.
  • NEA Management Company added most to Cloudflare in Q4 2021, an estimated $166M increase.
  • NEA Management Company's biggest Q4 2021 reduction was BILL Holdings, cutting an estimated $140M.
  • NEA Management Company fully exited Trillium Therapeutics Inc. in Q4 2021, selling an estimated $101M.
  • NEA Management Company's ten largest holdings make up 77% of its $4.95B portfolio in Q4 2021.
  • NEA Management Company opened 7 new positions and closed 12 in Q4 2021.
  • NEA Management Company's portfolio value fell 41% quarter-over-quarter to $4.95B.

Based on NEA Management Company's 13F filing for Q4 2021, filed 14 Feb 2022.